Dabur Research Foundation (DRF) is an Indian contract research organization offering pre-clinical services in drug discovery and development. It was established in 1979 to spearhead the research and development activities of Dabur, India's largest Ayurvedic medicine manufacturer.
References
- Articles about International Finance Corporation – Economic Times
- BioSpectrumIndia – the business of biotech – Customer relationships in a competitive market
- Elephant Capital buys stake in ClinTec Intl for Rs 58 cr
- Cosmetics testing kills 3.9 million animals - BioSpectrum Asia
- Burmans plan Rs 925-crore healthcare fund
- Dabur to re-expand its pharma research
Review of Literature
- Efficiency and mechanism of intracellular paclitaxel delivery by novel nanopolymer-based tumor-targeted delivery system, Nanoxel. Clinical and Translational Oncology({Template:Year).
- Anticancer and immunomodulatory activities of novel 1,8-naphthyridine derivatives. Journal of Enzyme Inhibition and Medicinal Chemistry({Template:Year).
- Emerging Significance of Flavonoids as P-Glycoprotein Inhibitors in Cancer Chemotherapy. Journal of Pharmacy & Pharmaceutical Sciences({Template:Year).